0001144204-15-059087.txt : 20151013
0001144204-15-059087.hdr.sgml : 20151012
20151013093401
ACCESSION NUMBER: 0001144204-15-059087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151007
FILED AS OF DATE: 20151013
DATE AS OF CHANGE: 20151013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-321-5554
MAIL ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kolchinsky Peter
CENTRAL INDEX KEY: 0001384859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 151154855
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001346824
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 151154856
BUSINESS ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-778-2500
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
v422054_4.xml
OWNERSHIP DOCUMENT
X0306
4
2015-10-07
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001346824
RA CAPITAL MANAGEMENT, LLC
20 PARK PLAZA, SUITE 1200
BOSTON
MA
02116
0
0
1
0
0001384859
Kolchinsky Peter
20 PARK PLAZA, SUITE 1200
BOSTON
MA
02116
0
0
1
0
Common Stock
2015-10-07
4
P
0
938041
10.6605
A
938041
I
See Footnote 1
Common Stock
2015-10-07
4
P
0
1250000
11.00
A
2188041
I
See Footnote 1
Common Stock
2015-10-07
4
P
0
27398
11.00
A
2215439
I
See Footnote 1
Common Stock
2015-10-08
4
P
0
21691
10.9979
A
2237130
I
See Footnote 1
The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities for purposes of Rule 16a-1(a)(1) under the Exchange Act in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of or transactions in the reported securities under Section 16a of the Exchange Act. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any of the securities reported herein.
The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund") and an account owned by Blackwell Partners, LLC (the "Blackwell Account"). Following the reported transactions, the Fund held 1,871,841 shares and the Blackwell Account held 365,289 shares. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Blackwell Account. Peter Kolchinsky is the sole manager of the Adviser. In their respective capacities, each of Mr. Kolchinsky and the Adviser may be deemed to beneficially own the reported securities for purposes of Section 13(d) of the Exchange Act.
/s/ Peter Kolchinsky Manager of RA Capital Management, LLC
2015-10-12
/s/ Peter Kolchinsky Individually
2015-10-12